Esophagus and Gastrointestinal Junction Tumors.
Esophagus and Gastrointestinal Junction Tumors.
Surg Clin North Am. 2020 Jun;100(3):507-521
Authors: Kurtom S, Kaplan BJ
Abstract
Esophageal squamous cell carcinoma and adenocarcinoma account for 95% of all esophageal malignancies. The rates of esophageal adenocarcinoma have increased in Western countries, making it the predominant type of esophageal cancer. Treatment of both types of cancer has transformed to a more minimally invasive approach, with endoscopic methods being used for superficial cancers and more frequent use of video-assisted and laparoscopic modalities for locally advanced tumors. The current National Comprehensive Cancer Network guidelines advocate a trimodal approach to treatment, with neoadjuvant chemoradiation and surgery for locally advanced cancers.
PMID: 32402297 [PubMed - as supplied by publisher]
Source: The Surgical Clinics of North America - Category: Surgery Authors: Kurtom S, Kaplan BJ Tags: Surg Clin North Am Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Gastroenterology | Laparoscopy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Science | Skin Cancer | Squamous Cell Carcinoma | Surgery